ABL Bio Inc. (KOSDAQ: A298380)
Health Care · Biotechnology · KR
₩48,000.00
-6.61% today · -47.5% 1Y
ABL Bio Inc. (KOSDAQ: A298380) operates in the Biotechnology industry within the Health Care sector. The company is valued at $2.00B.
Over the last twelve months the share price has lost 47.5%, trading between 47.35K and 257.50K.
Tweenvest scores ABL Bio Inc. across four factors: quality 45/100, value 51/100. Its strongest factor is value.
A298380 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $2.00B
- Revenue (TTM)
- $22.14M
- P/E
- —
- EPS
- -1,424.79
- Dividend yield
- —
- Beta (5Y)
- 0.28
- 52-week high
- ₩257,500.00
- 52-week low
- ₩47,350.00
- Avg volume (3M)
- —
- Shares outstanding
- 55.99M
- Employees
- —
- Next earnings
- —
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Nanjing Vazyme Biotech Co., LtdSHSE: 688105 | $2.05B | CN¥26.60 | -2.35% |
| Wuhan Healthgen Biotechnology Corp.SHSE: 688765 | $2.02B | CN¥37.86 | -4.97% |
| Genus plcLSE: GNS | $2.02B | £22.72 | -0.35% |
| Palvella Therapeutics, Inc.NasdaqGM: PVLA | $2.00B | $132.89 | -4.24% |
| ADARx Pharmaceuticals, Inc.NasdaqGS: ADRX | $1.99B | $17.78 | 0.00% |
| OliX Pharmaceuticals, IncKOSDAQ: A226950 | $1.99B | ₩117,300.00 | +0.43% |
| Vir Biotechnology, Inc.NasdaqGS: VIR | $1.98B | $11.36 | -2.91% |
| Jinyu Bio-technology Co., Ltd.SHSE: 600201 | $1.93B | CN¥11.84 | +1.98% |
Figures last refreshed Oct 11, 2026.